From disease modification to disease control in rheumatoid arthritis

被引:0
作者
Furst, DE
机构
关键词
rheumatoid arthritis; disease modification; disease-controlling anti-rheumatic therapy; ANTIRHEUMATIC DRUGS; CYCLOSPORINE; PLACEBO; METHOTREXATE; IMPROVEMENT;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In the development of therapies to treat rheumatoid arthritis, measurement of response is essential. Such measurement has incrementally advanced from symptom modification through radiological improvement to a requirement for change in inflammation, change in function, and the prevention of further structural damage.
引用
收藏
页码:S63 / S66
页数:4
相关论文
共 34 条
  • [1] ALARCON GS, 1992, J RHEUMATOL, V19, P1868
  • [2] Baumgartner S., 1996, Arthritis and Rheumatism, V39, pS74
  • [3] CLINICAL MEASUREMENT OF ANTI-INFLAMMATORY EFFECTS OF SALICYLATES IN RHEUMATOID ARTHRITIS
    BOARDMAN, PL
    HART, FD
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1967, 4 (5574): : 264 - +
  • [4] Boers Maarten, 1996, Arthritis and Rheumatism, V39, pS104
  • [5] Bresnihan B., 1996, Arthritis and Rheumatism, V39, pS73
  • [6] HYDROXYCHLOROQUINE COMPARED WITH PLACEBO IN RHEUMATOID-ARTHRITIS - A RANDOMIZED CONTROLLED TRIAL
    CLARK, P
    CASAS, E
    TUGWELL, P
    MEDINA, C
    GHENO, C
    TENORIO, G
    OROZCO, JA
    [J]. ANNALS OF INTERNAL MEDICINE, 1993, 119 (11) : 1067 - 1071
  • [7] *COMM OUTC MEAS RH, 1993, ARTHRITIS RHEUM, V36, P729
  • [8] ANTIRHEUMATIC DRUGS - A PROPOSED NEW CLASSIFICATION
    EDMONDS, JP
    SCOTT, DL
    FURST, DE
    BROOKS, P
    PAULUS, HE
    [J]. ARTHRITIS AND RHEUMATISM, 1993, 36 (03): : 336 - 339
  • [9] ESDAILE J, 1991, NEW ENGL J MED, V324, P150
  • [10] *FAO, GUID ANT ANT DRUGS